The Pharmaceutical Journal
Vol 269 No 7229 p883
21/28 December 2002

This article
Reprint
Photocopy

Products

Prescription Products
• ReQuip tablets
SPC changes
• Calpol Six Plus suspension
Discontinued products
• Filair inhaler
• ReQuip starter packs
Supply problems
• Sofratulle gauze
Counter medicines
• Packaging redesign

Recalls Amiodarone hydrochloride ampoules and Neomercazole tablets

Prescription Products

ReQuip tablets

A follow-on pack of ReQuip (ropinirole) tablets will be available from 6 January 2003 (GlaxoSmithKline). The packs will contain 42 x 0.5mg, 42 x 1mg and 63 x 2mg tablets; net price, £80. A new starter pack, containing 42 x 250µg, 42 x 0.5mg and 21 x 1mg tablets, has replaced the original starter pack (see below).

Back to Top

SPC changes

Calpol Six Plus suspension

The summaries of product characteristics for Calpol Six Plus (para-cetamol) suspension and Calpol Six Plus sugar and colour-free suspension have been updated (Pfizer Consumer Healthcare). The products are no longer recommended in children under six years of age. See SPC.

Back to Top

Discontinued products

Filair inhaler

Filair (beclometasone) 250µg inhaler, containing 200 doses, has been discontinued (Alpharma).

ReQuip starter packs

Starter packs of ReQuip (ropinirole) tablets containing 210 x 250µg tablets have been discontinued (GlaxoSmithKline).

Back to Top

Supply problems

Sofratulle gauze

Supply problems are being experienced with Sofratulle (framycetin sulphate) gauze (Aventis). Aventis is not holding any back orders and will be cancelling any existing orders. The company's customer services department can be contacted for enquiries (tel 0870 5133347).

Back to Top

Counter medicines

Packaging redesign

The packaging for products in the Calpol (paracetamol) range has been redesigned as shown below (Pfizer Consumer Healthcare).

Back to Top